Sort by
Refine Your Search
-
. Learning Objectives: Develop deep expertise in the principles and practices of scientific and medical communications. Understand the strategic role of communications in product lifecycle management. Gain
-
development to prepare fellows for a successful career in the pharmaceutical industry. Learning Objectives: Develop deep expertise in the principles and practices of scientific and medical communications
-
labeling and digital/social media campaigns. Compliance & Regulatory Intelligence Conduct regulatory intelligence to track evolving FDA/EMA/ICH guidance and competitor activity. Support inspection readiness
-
. Tracking cerebrovascular health in at-risk, but cognitively normal individuals will greatly facilitate early detection of those most at risk of developing dementia, allowing the opportunity for early
-
customers. Consistent and accurate glucose monitoring is the foundation of any diabetes management plan, so we're committed to continuous improvement in the way patients and professionals measure, track and
-
foundation of any diabetes management plan, so we’re committed to continuous improvement in the way patients and professionals measure, track and analyze glucose levels. Our science-driven products empower
-
of 2025. The Zelevinsky Postdoctoral Fellow appointments have a three-year term which is non-tenure-track and non-renewable. The position provides promising mathematicians the opportunity to begin their
-
of their choice, with options including Scientific Communications, Medical Information, Field Medical, or Medical Operations for the second year. Medical Affairs Fellowship Objectives: Develop in-depth knowledge
-
, 2025) in Psychology or a related field (e.g., Neuroscience, Education, Sociology), with an interest in studying adolescent development and/or wellbeing. Strong candidates will have a track record of
-
Communications, Medical Information, Field Medical, or Medical Operations for the second year. Medical Affairs Fellowship Objectives: · Develop in-depth knowledge of Intellia’s CRISPR gene editing technology